ArticleCardiovascular diabetology2023

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.

Stephan Sachs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.